28.02.2013 Views

autologous blood and marrow transplantation - Blog Science ...

autologous blood and marrow transplantation - Blog Science ...

autologous blood and marrow transplantation - Blog Science ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Table 4. Hematopoietic recovery following high-dose therapy<br />

Prince et al. 311<br />

All cycles<br />

combined Cycle I Cycle 2 Cycle 3 P value* P value t<br />

n 109 42 37 28<br />

ANC<br />

>0.5X10 9<br />

/L 10 (7-26) 10 (8-19) 10 (8-26) 10 (7-14) 0.1081 0.5233<br />

>1.0X10 9<br />

/L 10 (8-28) 10 (8-20) 10 (9-28) 10 (8-15) 0.2027 0.5545<br />

Platelets<br />

>20X10 9<br />

/L 13 (8-38) 13 (8-25) 13 (9-38) 14(10-21) 0.0644 0.4496<br />

>50X10 9<br />

/L 19(10-41) 17 (10-32) 20(11^10) 21 (12-41) 0.0013 0.0887<br />

>100X10 9<br />

/L 25 (10-152) 23 (10-45) 27 (13-124) 29 (14-152) 0.0123 0.0731<br />

*Repeated-measures ANOVA for patients undergoing all three cycles; flog rank test of<br />

recovery (see Figs. 1 <strong>and</strong> 2).<br />

4 <strong>and</strong> Fig. 1). G-CSF was required for a median of 11 days (range 6-32). Febrile<br />

neutropenia occurred after 67% of all cycles <strong>and</strong>, when it occurred, lasted for a<br />

median of 3 days (range 1-16). Admission to hospital was required after 78% of<br />

cycles, with a median stay in hospital of 5 days (range 2 -20). The reason for<br />

admission into hospital was febrile neutropenia in 84% of cases.<br />

Platelet recovery. The median time to platelets >20X10 9<br />

/L, 50X10 9<br />

/L, <strong>and</strong><br />

100X10 9<br />

/L was 13 (range 8-38), 19 (range 10-41), <strong>and</strong> 25 days (range 10-152),<br />

respectively (Table 4 <strong>and</strong> Fig. 1). A median of two platelet transfusions <strong>and</strong> two<br />

packed red <strong>blood</strong> cell transfusions were required after each cycle of treatment.<br />

There was significant slowing in platelet recovery between cycles. Analysis<br />

comparing time to recovery of platelets after each consecutive cycle of high-dose<br />

therapy (repeated-measures ANOVA), demonstrated that although recovery of platelets<br />

to >20X10 9<br />

/L was not significantly slowed (/ ><br />

=0.0644), recovery to >50X10 9<br />

/L<br />

(/>=0.0013) <strong>and</strong> >100X 10 9<br />

/L (/>=0.0123) was slowed (Table 4 <strong>and</strong> Fig. 2).<br />

Autograft CD34 content <strong>and</strong> ANC hematopoietic recovery. The range of<br />

autograft CD34 +<br />

correlation between CD34 +<br />

cells infused was 0.41 to 9.61X10 9<br />

/kg per cycle. There was a<br />

cell count <strong>and</strong> ANC recovery to >0.5X10 9<br />

/L<br />

(Spearman correlation: r=0.4904, P1.0X10 9<br />

/L (r=0.5015,<br />

P

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!